Janus Henderson Group’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.61M | Buy |
164,074
+10,817
| +7% | +$404K | ﹤0.01% | 878 |
|
|
2025
Q4 | $5.33M | Buy |
153,257
+111,598
| +268% | +$8.77M | ﹤0.01% | 915 |
|
|
2025
Q3 | $3.46M | Sell |
41,659
-63,061
| -60% | -$4.56M | ﹤0.01% | 1072 |
|
|
2025
Q2 | $7.69M | Sell |
104,720
-142,119
| -58% | -$10.3M | ﹤0.01% | 779 |
|
|
2025
Q1 | $13.5M | Sell |
246,839
-54,651
| -18% | -$3.33M | 0.01% | 644 |
|
|
2024
Q4 | $15.2M | Sell |
301,490
-22,527
| -7% | -$1.18M | 0.01% | 645 |
|
|
2024
Q3 | $15M | Sell |
324,017
-17,793
| -5% | -$632K | 0.01% | 622 |
|
|
2024
Q2 | $11.1M | Buy |
341,810
+76,761
| +29% | +$2.1M | 0.01% | 660 |
|
|
2024
Q1 | $6.68M | Buy |
265,049
+219,551
| +483% | +$5.19M | ﹤0.01% | 783 |
|
|
2023
Q4 | $1.48M | Sell |
45,498
-69
| -0.2% | -$1.9K | ﹤0.01% | 1413 |
|
|
2023
Q3 | $1.24M | Buy |
45,567
+21
| +0% | +$608 | ﹤0.01% | 1444 |
|
|
2023
Q2 | $1.01M | Sell |
45,546
-80,254
| -64% | -$1.85M | ﹤0.01% | 1611 |
|
|
2023
Q1 | $2.72M | Sell |
125,800
-17,015
| -12% | -$373K | ﹤0.01% | 1106 |
|
|
2022
Q4 | $2.9M | Sell |
142,815
-711,511
| -83% | -$17.8M | ﹤0.01% | 998 |
|
|
2022
Q3 | $21.9M | Buy |
854,326
+701,815
| +460% | +$18.8M | 0.01% | 654 |
|
|
2022
Q2 | $3.63M | Buy |
152,511
+23,247
| +18% | +$506K | ﹤0.01% | 907 |
|
|
2022
Q1 | $2.91M | Sell |
129,264
-47,327
| -27% | -$1.01M | ﹤0.01% | 1131 |
|
|
2021
Q4 | $3.5M | Buy |
176,591
+15,249
| +9% | +$309K | ﹤0.01% | 1157 |
|
|
2021
Q3 | $3.17M | Sell |
161,342
-30,276
| -16% | -$634K | ﹤0.01% | 1154 |
|
|
2021
Q2 | $4.22M | Sell |
191,618
-28,740
| -13% | -$640K | ﹤0.01% | 1097 |
|
|
2021
Q1 | $5.24M | Buy |
220,358
+79,693
| +57% | +$2.13M | ﹤0.01% | 1001 |
|
|
2020
Q4 | $3.68M | Buy |
140,665
+20,928
| +17% | +$441K | ﹤0.01% | 1024 |
|
|
2020
Q3 | $2.08M | Buy |
119,737
+21,642
| +22% | +$345K | ﹤0.01% | 1051 |
|
|
2020
Q2 | $1.65M | Buy |
98,095
+78,205
| +393% | +$1.1M | ﹤0.01% | 1056 |
|
|
2020
Q1 | $236K | Sell |
19,890
-46,434
| -70% | -$575K | ﹤0.01% | 1247 |
|
|
2019
Q4 | $803K | Buy |
66,324
+3,758
| +6% | +$52.3K | ﹤0.01% | 1244 |
|
|
2019
Q3 | $884K | Buy |
62,566
+7,874
| +14% | +$96.8K | ﹤0.01% | 1231 |
|
|
2019
Q2 | $610K | Sell |
54,692
-1,325
| -2% | -$14.8K | ﹤0.01% | 1247 |
|
|
2019
Q1 | $658K | Buy |
+56,017
| New | +$696K | ﹤0.01% | 1212 |
|
Other funds holding CORT
ISL
VPM
VCM
PA
